A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B

Clinical trial NCT06441630 · RECRUITING

Trial details

NCT number: NCT06441630
Sponsor: Addpharma Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2024-07-31
Primary completion: 2025-09-01
Enrollment: 251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.